Sort
10,766 grants matching “checkpoint inhibitor”
Impact of local and systemic cellular senescence toward Triple Negative Breast Cancer growth and drug therapy
$52,694Irfan Khan · Georgetown University · F30 · FY2023 · CA
Mechanistic Dissection and Therapeutic Targeting of B7x in Cancer
$52,694Christopher D Nishimura · Albert Einstein College Of Medicine · F30 · FY2023 · CA
Contribution of PAG to Immune Synapse Organization and PD-1 Function
$52,694Emily Kathryn Moore · Columbia University Health Sciences · F30 · FY2023 · CA
Clinical trial data analysis to design novel treatment regimens in oncology
$52,694Deborah Plana · Harvard Medical School · F30 · FY2023 · CA
Rab4A Control of Liver Dysfunction in Mouse Models of Systemic Lupus Erythematosus.
$52,694Akshay Patel · Upstate Medical University · F30 · FY2023 · DK
Host and microbe-dependent mechanisms of enhanced autoimmune susceptibility driven by checkpoint inhibitors
$52,694Vanessa Salazar · Cleveland Clinic Lerner Com-Cwru · F31 · FY2023 · AI
Investigating the Roles of Phospholipase A2s and Diacylglycerol Signaling in Ferroptosis
$52,694Annie J Lin · Columbia University Health Sciences · F30 · FY2023 · CA
Alternate splicing as a source of shared neoantigens in a non-small cell lung cancer
$52,694Ryan Englander · University Of Connecticut Sch Of Med/Dnt · F30 · FY2023 · CA
Augmenting Pancreatic Cancer Immunotherapy via TGFβ Pathway Inhibition
$52,694Daniel R Principe · University Of Illinois At Chicago · F30 · FY2023 · CA
Neoantigen-specific T cells in a novel cutaneous squamous cell carcinoma model
$52,694Anngela Christina Adams · University Of Arizona · F30 · FY2023 · CA
The role of decoy receptor IL-1R2 in Treg biology and anti-tumor immunity
$52,694Ireneusz Habrylo · University Of California, San Francisco · F31 · FY2023 · CA
Investigating Immunosuppression in Beta-catenin-mutated Hepatocellular Carcinoma for Improved Precision Medicine Therapeutics
$52,694Brandon Lehrich · University Of Pittsburgh At Pittsburgh · F30 · FY2023 · CA
Discovery of myeloid immune features predictive of response to cancer immunotherapy in prostate cancer
$52,694Elizabeth McCarthy · University Of California, San Francisco · F30 · FY2023 · CA
The Role of SPON1 Expressing Inflammatory Monocytes in Promoting Lung Cancer Metastasis.
$52,694Nisitha Sengottuvel · Univ Of North Carolina Chapel Hill · F30 · FY2023 · CA
Identifying Effective Immune Checkpoint Therapy Strategies in Triple Negative Breast Cancer
$52,542Daniel Patrick Hollern · Univ Of North Carolina Chapel Hill · F32 · FY2016 · CA
Genetic contributions to T cell mediated immunopathology after viral infection
$52,488Brian Martin Sullivan · Scripps Research Institute, The · R21 · FY2020 · AI
DNA Methylation Inhibitor Therapy for Testicular Cancer
$52,440Michael J Spinella · University Of Illinois At Urbana-Champaign · R01 · FY2022 · CA
Yale SPORE in Skin Cancer
$52,414Marcus W Bosenberg · Yale University · P50 · FY2021 · CA
Tumor Biology and Microenvironment
$52,358Kay-Uwe Wagner · Wayne State University · P30 · FY2024 · CA
Discovery of protein-protein interaction inhibitors of Replication Protein A
$52,190James Patrone · Vanderbilt University · F32 · FY2013 · CA
Regulation of proliferation in vertebrate embryonic mesodermal progenitors
$52,190Cortney M Bouldin · University Of Washington · F32 · FY2012 · GM
Project 05: Translational Therapeutics (TT)
$51,953David P Carbone · Ohio State University · P30 · FY2024 · CA
Project 05: Translational Therapeutics (TT)
$51,950David P Carbone · Ohio State University · P30 · FY2023 · CA
Computational Methods for Inferring Single-cell DNA Methylation and its Spatial Landscape
$51,944Wenpin Hou · Johns Hopkins University · K99 · FY2022 · HG
Molecular Imaging
$51,833Nerissa Therese Viola · Wayne State University · P30 · FY2024 · CA